Evidence map›Paper›PMID 33155666›Full record

ReviewInternational journal of molecular medicine2021

Antioxidant and anti‑inflammatory mechanisms of action of astaxanthin in cardiovascular diseases (Review).

Carolina Parga Martins Pereira, Ana Carolina Remondi Souza, Andrea Rodrigues Vasconcelos, Pietra Sacramento Prado, José João Name

Open access · hybridAbstract readReview
In one paragraph

Review in International journal of molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 166 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Carotenoids and Their Interaction with the Immune System.Antioxidants (Basel, Switzerland) · 2025
    Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Carolina Parga Martins PereiraKilyos Assessoria, Cursos e Palestras, São Paulo, SP 01311‑100, Brazil.
Ana Carolina Remondi SouzaKilyos Assessoria, Cursos e Palestras, São Paulo, SP 01311‑100, Brazil.
Andrea Rodrigues VasconcelosDepartment of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP 05508‑000, Brazil.
Pietra Sacramento PradoKilyos Assessoria, Cursos e Palestras, São Paulo, SP 01311‑100, Brazil.
José João NameKilyos Assessoria, Cursos e Palestras, São Paulo, SP 01311‑100, Brazil.
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases are the most common cause of mortality worldwide. Oxidative stress and inflammation are pathophysiological processes involved in the development of cardiovascular diseases; thus, anti‑inflammatory and antioxidant agents that modulate redox balance have become research targets so as to evaluate their molecular mechanisms of action and therapeutic properties. Astaxanthin, a carotenoid of the xanthophyll group, has potent antioxidant properties due to its molecular structure and its arrangement in the plasma membrane, factors that favor the neutralization of reactive oxygen and nitrogen species. This carotenoid also has prominent anti‑inflammatory activity, possibly interrelated with its antioxidant effect, and is also involved in the modulation of lipid and glucose metabolism. Considering the potential beneficial effects of astaxanthin on cardiovascular health evidenced by preclinical and clinical studies, the aim of the present review was to describe the molecular and cellular mechanisms associated with the antioxidant and anti‑inflammatory properties of this carotenoid in cardiovascular diseases, particularly atherosclerosis. The beneficial properties and safety profile of astaxanthin indicate that this compound may be used for preventing progression or as an adjuvant in the treatment of cardiovascular diseases.

Indexed as

Cardiovascular DiseasesAntioxidantsGlucoseHumansLipid MetabolismXanthophyllsAntioxidantsastaxanthineGlucoseXanthophyllsantioxidantastaxanthinatherosclerosiscardiovascular diseasecarotenoidsinflammationoxidative stress

Identifiers

PMID33155666
PMCPMC7723678
OpenAlexW3096532228

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.